Amanta Healthcare Limited (NSE:AMANTA)

Market Cap	6.17B
Revenue (ttm)	2.88B +4.7%
Net Income	148.75M +41.7%
EPS	4.33 +16.7%
Shares Out	34.34M
PE Ratio	41.52
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,723
Open	179.80
Previous Close	171.24
Day's Range	179.80 - 179.80
52-Week Range	92.00 - 179.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Amanta Healthcare

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory ca...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 522
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMANTA

Financial Performance

In fiscal year 2026, Amanta Healthcare's revenue was 2.88 billion, an increase of 4.72% compared to the previous year's 2.75 billion. Earnings were 148.75 million, an increase of 41.66%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 8, 2026

Data Sources Report a data error